Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma
Condition:   Plasma Cell Myeloma
Intervention:   Drug: SAR442085
Sponsor:   Sanofi
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 10, 2019 / by / in
Comments